From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast: Yes I am bloody keen on Optibiotix after its interims today

By Tom Winnifrith | Wednesday 27 September 2023


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


In today's Bearcast I discuss my morning with the Cheshire fuzz tomorrow, Optibiotix (OPTI), Ben's Creek (BEN), Itsarm (ITS) and Bluebird Merchant Ventures (BMV). Footnote: after hours in a statement that does not wash Ben's Creek stated: "Further to the Company's notification on 13 September 2023, that there will be a small delay in the Company's full year results announcement and the publication of the Company's annual report and accounts for the year ended 31 March 2023.The Company now intends to publish its annual report and accounts along with the accompanying final results announcement on or before 29 September 2023.". RED FLAG
You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

PICH

Pitch Pit – this stinks

 

GEX

Georgina Energy: Lyin’ Yet again

Time left: 11:07:31